For decades, oral health care has mainly focused on preventing cavities and gum disease. However, scientific research has ...

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

Successful robotic-assisted thyroidectomy performed at Medicover Cancer Institute, Hyderabad, offering advanced care with ...

The positive CHMP opinion is based on data from the CABINET Phase III trial, which investigated Cabometyx versus placebo in people living with advanced pNETs or epNETs, whose disease had progressed ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

Transforming rural healthcare! Dr. Teresa Owens Tyson leads the Health Wagon, bringing vital diagnostic access, mobile ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for metabolic ...

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...

Discover why your hands age faster than your face and reveal your true age. Learn the hidden causes and proven solutions for ...